Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Horby PW. et al, (2020)

taleNeprilysin and Neprilysin inhibition in chronic kidney disease.

Judge PK. and Haynes R., (2020), Curr Opin Nephrol Hypertens

Conventional and Genetic Evidence on the Association between Adiposity and CKD.

Zhu P. et al, (2020), J Am Soc Nephrol

Effect of hydroxychloroquine in hospitalized patients with COVID-19

LANDRAY M. and HORBY P., (2020), New England Journal of Medicine

Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group None., (2020), Lancet

International consensus definitions of clinical trial outcomes for kidney failure: 2020

Levin A. et al, (2020), Kidney International, 98, 849 - 859

Lopinavir-ritonavir in Hospitalised Patients with COVID-19 – a randomised, controlled, open-label, platform trial

LINSELL L. et al, (2020), The Lancet

CONVENTIONAL AND GENETIC EVIDENCE ON THE ASSOCIATION BETWEEN ADIPOSITY AND CHRONIC KIDNEY DISEASE

HERRINGTON W. et al, (2020), Journal of the American Society of Nephrology

Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom.

Hopewell JC. et al, (2020), Eur Heart J, 41, 3336 - 3342

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.

WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group None. et al, (2020), JAMA

Blood pressure and kidney disease: chicken or egg (or both)?

Staplin N. et al, (2020), Kidney Int, 98, 547 - 549

Erratum: The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study.

Herrington WG. et al, (2020), Clin Kidney J, 13

Evaluation of Month-24 Efficacy and Safety of Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration: The MERLOT Randomized Clinical Trial.

Jackson TL. et al, (2020), JAMA Ophthalmol, 138, 835 - 842

An unusual presentation of propylthiouracil-induced anti-MPO and PR3 positive ANCA vasculitis with associated anti-GBM antibodies, IgA nephropathy and an IgG4 interstitial infiltrate: a case report.

Galante JR. et al, (2020), BMC Nephrol, 21

LDL-cholesterol reduction in chronic kidney disease: options beyond statins.

Goonasekera MA. et al, (2020), Curr Opin Nephrol Hypertens

Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report.

RECOVERY Collaborative Group None. et al, (2020), N Engl J Med

Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

LANDRAY M. et al, (2020), New England Journal of Medicine

Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial.

Horby P. et al, (2020)

Cross-sectional associations between central and general adiposity with albuminuria: observations from 400,000 people in UK Biobank

Zhu P. et al, (2020), International Journal of Obesity

Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report

Horby P. et al, (2020)

Load More

1
2
3
4
5
6
7

Include forthcoming?